MedicarePartD.guide

A non-government resource built from CMS public data

Multiple sclerosis drugs on every 2026 Virginia Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 9 stand-alone Part D plans in Virginia cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days
Multiple sclerosis drugs by 2026 Virginia Part D plan
DrugWellcare Classic$0.00/moS4802-069Wellcare Value Script$0.00/moS4802-142Humana Basic Rx Plan$0.00/moS5884-132Humana Value Rx Plan$0.00/moS5884-186AARP Medicare Rx Saver from UHC$39.60/moS5921-352SilverScript Choice$78.20/moS5601-014Humana Premier Rx Plan$87.60/moS5884-153AARP Medicare Rx Preferred from UHC$100.80/moS5921-389HealthSpring Assurance Rx$133.80/moS5617-216
KesimptaofatumumabNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredTier 5PA25%QL 1.6/28d
teriflunomidegeneric AubagioTier 5PA25%QL 30/30dTier 5PA25%QL 30/30dTier 4PA33%QL 30/30dTier 4PA32%QL 30/30dNot coveredTier 5PA25%QL 30/30dTier 4PA50%QL 30/30dTier 435%QL 30/30dTier 5PA25%QL 30/30d
dimethyl fumarategeneric TecfideraTier 4PA31%QL 56/28dTier 4PA40%QL 56/28dNot coveredNot coveredTier 434%QL 56/28dNot coveredTier 4PA50%QL 14/30dTier 435%QL 56/28dTier 4PA31%QL 14/30d
Vumeritydiroximel fumarateNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
fingolimodgeneric GilenyaTier 5PA25%QL 30/30dTier 5PA25%QL 30/30dTier 3PA25%QL 30/30dTier 3PA20%QL 30/30dTier 434%QL 30/30dTier 5PA25%QL 30/30dTier 3PA$45.00QL 30/30dTier 435%QL 30/30dNot covered
MayzentsiponimodNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
ZeposiaozanimodNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
MavencladcladribineNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.